Social network you want to login/join with:
Ellipses Pharma is a global drug development company headquartered in London, focused on accelerating the development of cancer treatments through an innovative drug development model. This model combines unbiased vetting to de-risk initial asset selection, the expertise of a Scientific Affairs Group comprising over 300 leading oncologists, and uninterrupted funding to minimize the time to advance lead products through clinical trials and reach patients.
Position: CMC Director
Reporting to the Head of CMC, the CMC Director will oversee all CMC-related activities across Ellipses' portfolio of pre-clinical and clinical assets. The role involves close collaboration with the Clinical Operations team, Head of Translational Medicine, Asset Leader, and other internal and external stakeholders.
Key Responsibilities:
- Develop and lead CMC activities for drug substance and drug product development, manufacture, and supply, from in-license through clinical development and registration/out-licensing for assigned assets.
- Establish and manage development, manufacturing, and supply chain activities, including CDMO selection, qualification, and management, with support from external SMEs as needed.
- Direct and manage CMC operational activities at third-party suppliers.
- Support Clinical Trial Managers in coordinating external CMC consultancies to ensure timely delivery of CMC activities supporting project milestones.
- Act as CMC technical author and lead for CMC sections of regulatory submissions, briefing documents, and interactions with authorities.
- Review cGMP manufacturing batch records, CMC regulatory and quality documents, and prepare technical reports, publications, and presentations. Work with the QP for batch release and certification.
- Manage CMC projects and integrate CMC plans into the Asset strategy, including risk analysis and mitigation.
- Contribute to annual budgeting for CMC activities and monitor expenditure to align with financial plans.
- Collaborate with the business development team to provide CMC expertise during due diligence for potential new assets.
Skills and Experience:
- Life science degree or related discipline with at least 5 years of broad CMC sponsor-side experience.
- Experience in oncology and expedited development pathways (e.g., Breakthrough Therapy, Fast Track) is desirable.
- Significant biotech experience within a clinical trial sponsor organization.
- Specialist in drug product or drug substance with a comprehensive understanding of the CMC lifecycle.
- Ability to serve as an internal CMC expert across asset types, preferably biologics, utilizing external expertise as needed.
- Experience across pre-clinical, Phase 1, and Phase 2 trials.
- Proficiency in authoring CMC sections for regulatory filings and managing complex regulatory issues.
- Strong project management skills, including planning, prioritization, and managing multiple projects with strict deadlines and external partners.
- Experience working internationally with partners and providers.